Acute ataxic neuropathy as an incomplete Miller Fisher syndrome triggered by hepatitis B virus reactivation: a case report with negative GQ1b antibody
This case report describes the first documented instance of acute ataxic neuropathy, an incomplete variant of Miller Fisher syndrome triggered by hepatitis B virus reactivation, which presented with negative anti-GQ1b antibodies and no ophthalmoplegia but resolved following combined treatment with intravenous immunoglobulin and antiviral therapy.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The human nervous system is a vast network of cables that carries signals between the brain and the rest of the body, allowing us to move, feel, and balance. Sometimes, the body's own immune system, which is designed to fight off infections, mistakenly turns against these nerve cables. This confusion can lead to a group of conditions known as Guillain-Barré syndrome, where the immune attack causes weakness, numbness, and a loss of reflexes. A specific and well-known version of this condition is called Miller Fisher syndrome. In its classic form, this syndrome presents with a distinct trio of symptoms: the eyes become paralyzed or unable to move, the person loses their balance and coordination, and the reflexes in the limbs disappear. While doctors have long known that certain infections, like those caused by bacteria or other viruses, can trigger this immune confusion, the link to the hepatitis B virus has remained a mystery, particularly for a rare variation of the syndrome that lacks the eye paralysis.
In a recent case report, researchers from Beijing Ditan Hospital describe a patient who helped solve this puzzle. The patient was a thirty-one-year-old woman with a long history of chronic hepatitis B. She had stopped taking her antiviral medication months earlier without consulting a doctor, a decision that allowed the virus to reactivate and multiply rapidly within her body. Soon after, she began to experience a strange and progressive set of symptoms. Her legs felt numb, and her walk became increasingly unsteady. Within weeks, the numbness spread to her hands, and she found she could no longer stand without assistance. Crucially, her eyes moved normally, and she retained full strength in her muscles; the only things failing were her balance and her reflexes. This specific pattern—severe balance loss and absent reflexes without eye paralysis or muscle weakness—is known as acute ataxic neuropathy, a rare and incomplete form of Miller Fisher syndrome.
When the medical team examined her, they found clear signs that her liver was under severe stress from the reactivated virus, with high levels of viral particles circulating in her blood. A spinal tap, a procedure used to analyze the fluid surrounding the brain and spinal cord, revealed a classic sign of nerve inflammation: the fluid contained high levels of protein but very few white blood cells. This combination, known as albuminocytologic dissociation, is a hallmark of the nerve damage seen in Miller Fisher syndrome. However, a key piece of the usual diagnostic picture was missing. Doctors typically look for a specific antibody called anti-GQ1b, which is found in the blood or spinal fluid of most people with classic Miller Fisher syndrome and is believed to be the weapon the immune system uses to attack the nerves. In this woman, that antibody was completely absent, and her eyes never became paralyzed.
Despite the missing antibody and the unusual lack of eye symptoms, the medical team treated her for the suspected nerve condition. She received two courses of a therapy called intravenous immunoglobulin, which involves infusing healthy antibodies into the bloodstream to calm the immune system's overreaction. At the same time, she was restarted on antiviral medication to suppress the hepatitis B virus. The treatment worked. After the first round of therapy, her condition stopped getting worse. Over the following weeks, she began to regain her ability to move. By the time she was discharged, her viral load had dropped significantly, and her liver function was improving. Two months after leaving the hospital, she could walk and stand completely on her own, and her balance tests returned to normal.
This case is significant because it is the first time this specific incomplete form of Miller Fisher syndrome has been linked to a reactivation of the hepatitis B virus. It also demonstrates that the absence of the usual antibody and the absence of eye paralysis do not rule out the diagnosis. The researchers suggest that the reactivated virus likely triggered an immune response that attacked the nerves, even without the presence of the specific antibody typically associated with the condition. The presence of other markers in her spinal fluid, such as specific protein bands, supported the idea that her immune system was actively attacking her own nervous system from within. This finding serves as a reminder to doctors that when a patient with a history of hepatitis B suddenly develops severe balance problems and lost reflexes, the cause may be a rare nerve disorder triggered by the virus, even if the classic signs are not all present. Early recognition and treatment can lead to a full recovery, turning a potentially devastating condition into a temporary setback.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.